drugset / Trial / NCT03566940
A Study to Assess the Safety, Reactogenicity and Immunogenicity of a Trivalent Inactivated Poliovirus Vaccine (IPV) Based on Sabin Strains Compared to Conventional Salk IPV in a 6, 10 and 14 Weeks of Age Immunization Schedule
RandomizedSequentialDouble-blindPrevention
Summary
The purpose of this study is to assess the safety and reactogenicity of 3 different dose levels of inactivated poliovirus vaccine based on Sabin strains (sIPV) in healthy participants, using conventional Salk IPV (cIPV) as an active control.
Timeline
- Start
- 2018-07-31
- Primary completion
- 2019-08-07
- Completion
- 2019-10-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | cIPV | Vaccine | 0.5 ml | Intramuscular |
| Subject | sIPV | Vaccine | 0.5 ml | Intramuscular |
Indications
No indication recorded.